评估溃疡性结肠炎组织学炎症所需活检数量的最佳方案:一项回顾性队列研究
本研究从前瞻性生物样本库回顾性获取溃疡性结肠炎患者≥4块直肠乙状结肠活检及临床、内镜资料,盲法判读组织学与内镜视频,以4块活检的Robarts组织病理学指数(RHI)参考评分比较1、2、3块活检的估计值。结果显示2块和3块活检与4块活检一致性可接受,1块活检不可接受;内镜下活动期患者需3块活检。
要点
- 2块和3块活检的RHI评分与4块参考评分一致性可接受,1块活检不可接受。
- 内镜下活动期患者亚组分析显示需要3块活检。
- 额外取样结肠部位的组织学缓解率低于单纯直肠乙状结肠取样(33.3% vs 61.9%,P=0.1)。
核心结论
- 在单个结肠节段使用RHI可靠评估疾病活动至少需要2块活检,保守而言需3块活检。
- 需进一步研究内镜下活动期患者及取样部位。
研究设计与样本
- 回顾性队列研究,从前瞻性生物样本库获取≥4块直肠乙状结肠活检样本及临床和内镜数据。
- 组织学与内镜视频均盲法判读。
- 共46例患者,N=287块活检。
主要发现
- 2块活检RHI评分容差区间为-7.66至4.79,3块活检为-4.86至3.46,与4块活检评分一致性可接受。
- 1块活检RHI评分容差区间为-13.99至7.78,一致性不可接受。
- 2块、3块和4块活检的平均RHI评分分别为6.1±9.6(P=0.36)、6.8±10.5(P=0.7)、7.5±11.2,1块活检估计值较低为4.4±8.1(P=0.06)。
- 2块、3块和4块活检方法的组织学缓解率相同,均为65.2%(P=1.0)。
- 亚组分析显示内镜下活动期患者需要3块活检。
关键数值与推荐
- 一致性判定采用双变量误差变量回归分析,接受区间为±8.25。
- 2块活检容差区间-7.66至4.79,3块活检-4.86至3.46,均在接受区间内。
- 1块活检容差区间-13.99至7.78,超出接受区间。
临床怎么用
- 这些结果对临床试验和实践中的活检策略有启示。
- 在单个结肠节段使用RHI评估疾病活动时,至少需要2块活检,保守而言需3块活检。
- 内镜下活动期患者需3块活检。
局限性
- 需进一步研究内镜下活动期患者及取样部位。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The optimal ulcerative colitis biopsy protocol is unclear. AIM: To evaluate the number of biopsies required to accurately assess microscopic disease activity in ulcerative colitis METHODS: Biopsies from patients with ≥4 rectosigmoid samples, and clinical and endoscopic data, were retrospectively obtained from a prospective biobank. Histology and endoscopic videos were read blindly. A 4-biopsy Robarts Histopathology Index (RHI) reference score, consisting of the worst item-level ratings from four biopsies, was compared to 1-, 2- and 3-biopsy estimates. Agreement was determined using bivariate errors-in-variable regression analysis (acceptance interval: ±8.25). Endoscopic activity and disease location subgroup analyses were also performed. RESULTS: Forty-six patients had ≥4 rectosigmoid biopsies available (N = 287). The 2-biopsy (tolerance interval: -7.66, 4.79) and 3-biopsy (tolerance interval: -4.86, 3.46) RHI scores demonstrated acceptable agreement with 4-biopsy scores. One-biopsy scores demonstrated unacceptable agreement (tolerance interval: -13.99, 7.78). Mean RHI scores using the 2-, 3- and 4-biopsy approaches were similar (6.1 ± 9.6 P = 0.36; 6.8 ± 10.5, P = 0.7; 7.5 ± 11.2), whereas the 1-biopsy estimate was lower (4.4 ± 8.1, P = 0.06). Histological remission rates were identical for the 2-, 3- and 4-biopsy methods (65.2%, P = 1.0). Subgroup analysis demonstrated that three biopsies were required in patients with endoscopically active disease. Sampling additional colonic locations yielded lower histological remission rates compared to rectosigmoid sampling alone (33.3% vs 61.9%, P = 0.1). CONCLUSIONS: A minimum of two - conservatively, three - biopsies are required to reliably assess disease activity in a single colonic segment using the RHI. Further studies are needed of endoscopically active patients and sampling locations. These results have implications for biopsy strategies in clinical trials and practice.
引用
- Battat R, Vande Casteele N, Pai RK, et al. Evaluating the optimum number of biopsies to assess histological inflammation in ulcerative colitis: a retrospective cohort study. Aliment Pharmacol Ther. 2020. PMID: 32981088. doi:10.1111/apt.16083
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。